BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1869408)

  • 21. Amplitude increase of the multifocal electroretinogram during light adaptation.
    Kondo M; Miyake Y; Piao CH; Tanikawa A; Horiguchi M; Terasaki H
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2633-7. PubMed ID: 10509660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rod ERG diurnal rhythm in some patients with dominant retinitis pigmentosa.
    Sandberg MA; Baruzzi CM; Hanson AH; Berson EL
    Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):494-8. PubMed ID: 3343106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa.
    Sandberg MA; Weigel-DiFranco C; Rosner B; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1693-8. PubMed ID: 8675413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Stiles-Crawford effect in retinitis pigmentosa.
    Birch DG; Sandberg MA; Berson EL
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):157-64. PubMed ID: 7056630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diurnal rhythm in the human rod ERG. Relationship to cyclic lighting.
    Birch DG; Sandberg MA; Berson EL
    Invest Ophthalmol Vis Sci; 1986 Feb; 27(2):268-70. PubMed ID: 3943951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
    Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cone electroretinogram amplitude growth with light adaptation in patients with retinitis pigmentosa.
    Yamamoto S; Hayashi M; Takeuchi S
    Acta Ophthalmol Scand; 2000 Aug; 78(4):403-6. PubMed ID: 10990040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifocal rod electroretinograms.
    Hood DC; Wladis EJ; Shady S; Holopigian K; Li J; Seiple W
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1152-62. PubMed ID: 9620074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rod- versus cone-driven ERGs at different stimulus sizes in normal subjects and retinitis pigmentosa patients.
    Aher AJ; McKeefry DJ; Parry NRA; Maguire J; Murray IJ; Tsai TI; Huchzermeyer C; Kremers J
    Doc Ophthalmol; 2018 Feb; 136(1):27-43. PubMed ID: 29134295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid off-response and retinal receptor diseases.
    Iijima H
    Jpn J Ophthalmol; 1984; 28(2):147-58. PubMed ID: 6471606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acuity recovery and cone pigment regeneration after a bleach in patients with retinitis pigmentosa and rhodopsin mutations.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2457-61. PubMed ID: 10476820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn.
    Wada Y; Sandberg MA; McGee TL; Stillberger MA; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1735-41. PubMed ID: 15851576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-frequency damped electroretinographic wavelets in young asymptomatic patients with dominant retinitis pigmentosa: a new electroretinographic finding.
    Lam BL; Liu M; Hamasaki DI
    Ophthalmology; 1999 Jun; 106(6):1109-13. PubMed ID: 10366078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding changes in the b-wave of the ERG caused by heterogeneous receptor damage.
    Hood DC; Shady S; Birch DG
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2477-88. PubMed ID: 8163337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth in amplitude of the human cone electroretinogram with light adaptation.
    Gouras P; MacKay CJ
    Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):625-30. PubMed ID: 2703304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term inter-visit variability of erg amplitudes in normal subjects and patients with retinitis pigmentosa.
    Fishman GA; Chappelow AV; Anderson RJ; Rotenstreich Y; Derlacki DJ
    Retina; 2005 Dec; 25(8):1014-21. PubMed ID: 16340532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal cone electroretinograms in dominant retinitis pigmentosa with reduced penetrance.
    Sandlberg MA; Effron MH; Berson EL
    Invest Ophthalmol Vis Sci; 1978 Nov; 17(11):1096-101. PubMed ID: 700959
    [No Abstract]   [Full Text] [Related]  

  • 40. Foveal cone electroretinograms in retinitis pigmentosa and juvenile maular degeneration.
    Sandberg MA; Jacobson SG; Berson EL
    Am J Ophthalmol; 1979 Oct; 88(4):702-7. PubMed ID: 507142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.